AAAAAA

   
Results: 1-16 |
Results: 16
ENDOTHELIAL-CELL TRANSFECTION WITH CATIONIC LIPOSOMES AND HERPES-SIMPLEX THYMIDINE KINASE MEDIATED KILLING
Authors: FIFE K BOWER M COOPER RG STEWART L ETHERIDGE CJ COOMBES RC BULUWELA L MILLER AD
Citation: K. Fife et al., ENDOTHELIAL-CELL TRANSFECTION WITH CATIONIC LIPOSOMES AND HERPES-SIMPLEX THYMIDINE KINASE MEDIATED KILLING, Gene therapy, 5(5), 1998, pp. 614-620
ANTI-ANGIOGENIC GENE-THERAPY
Authors: FIFE K BULUWELA L MILLER A COOMBES RC BOWER M
Citation: K. Fife et al., ANTI-ANGIOGENIC GENE-THERAPY, British Journal of Cancer, 78, 1998, pp. 52-52
A PHASE-II STUDY OF THALIDOMIDE FOR KAPOSIS-SARCOMA - ACTIVITY AND CORRELATION WITH KSHV DNA LOAD
Authors: BOWER M HOWARD M GRACIE F PHILLIPS R FIFE K
Citation: M. Bower et al., A PHASE-II STUDY OF THALIDOMIDE FOR KAPOSIS-SARCOMA - ACTIVITY AND CORRELATION WITH KSHV DNA LOAD, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 76-76
PHASE-II TRIAL OF 13-CIS-RETINOIC ACID FOR POOR-RISK HIV-ASSOCIATED KAPOSIS-SARCOMA
Authors: BOWER M FIFE K LANDAU D GRACIE F PHILLIPS RH GAZZARD BG
Citation: M. Bower et al., PHASE-II TRIAL OF 13-CIS-RETINOIC ACID FOR POOR-RISK HIV-ASSOCIATED KAPOSIS-SARCOMA, International journal of STD & AIDS, 8(8), 1997, pp. 518-521
ISOLATION AND CHARACTERIZATION OF EXODUS-2, A NOVEL C-C CHEMOKINE WITH A UNIQUE 37 AMINO-ACID CARBOXYL-TERMINAL EXTENSION
Authors: HROMAS R KIM CH KLEMSZ M KRATHWOHL M FIFE K COOPER S SCHNIZLEINBICK C BROXMEYER HE
Citation: R. Hromas et al., ISOLATION AND CHARACTERIZATION OF EXODUS-2, A NOVEL C-C CHEMOKINE WITH A UNIQUE 37 AMINO-ACID CARBOXYL-TERMINAL EXTENSION, The Journal of immunology, 159(6), 1997, pp. 2554-2558
MYELOSUPPRESSION IN-VITRO AND IN-VIVO BY NEWLY IDENTIFIED MEMBERS OF THE CYSTEINE CYSTEINE (CC), CXC AND C CHEMOKINE FAMILY AND SYNERGISTICSUPPRESSION IN-VIVO BY COMBINATIONS OF THESE CHEMOKINES
Authors: BROXMEYER HE PELUS LM HROMAS R KWON B YOUNG B FIFE K KRATHWOHL MD KIM C WHITE JR HANGOC G COOPER S
Citation: He. Broxmeyer et al., MYELOSUPPRESSION IN-VITRO AND IN-VIVO BY NEWLY IDENTIFIED MEMBERS OF THE CYSTEINE CYSTEINE (CC), CXC AND C CHEMOKINE FAMILY AND SYNERGISTICSUPPRESSION IN-VIVO BY COMBINATIONS OF THESE CHEMOKINES, Blood, 90(10), 1997, pp. 2113-2113
CLONING AND CHARACTERIZATION OF EXODUS, A NOVEL BETA-CHEMOKINE
Authors: HROMAS R GRAY PW CHANTRY D GODISKA R KRATHWOHL M FIFE K BELL GI TAKEDA J ARONICA S GORDON M COOPER S BROXMEYER HE KLEMSZ MJ
Citation: R. Hromas et al., CLONING AND CHARACTERIZATION OF EXODUS, A NOVEL BETA-CHEMOKINE, Blood, 89(9), 1997, pp. 3315-3322
CHEMOTHERAPY FOR OVARIAN GERM-CELL TUMORS
Authors: BOWER M FIFE K HOLDEN L PARADINAS FJ RUSTIN GJS NEWLANDS ES
Citation: M. Bower et al., CHEMOTHERAPY FOR OVARIAN GERM-CELL TUMORS, European journal of cancer, 32A(4), 1996, pp. 593-597
A PHASE-II TRIAL OF 13 CIS RETINOIC ACID FOR POOR-RISK AIDS-ASSOCIATED KAPOSIS-SARCOMA
Authors: GRACIE F BOWER M FIFE K LANDAU D PHILLIPS R GAZZARD B
Citation: F. Gracie et al., A PHASE-II TRIAL OF 13 CIS RETINOIC ACID FOR POOR-RISK AIDS-ASSOCIATED KAPOSIS-SARCOMA, AIDS, 10, 1996, pp. 123-123
RADIOTHERAPY FOR THE LOCAL-CONTROL OF MEDULLARY-THYROID CANCER
Authors: FIFE K BOWER M HARMER C
Citation: K. Fife et al., RADIOTHERAPY FOR THE LOCAL-CONTROL OF MEDULLARY-THYROID CANCER, British Journal of Cancer, 74, 1996, pp. 37-37
RECENT INSIGHTS INTO THE PATHOGENESIS OF KAPOSIS-SARCOMA
Authors: FIFE K BOWER M
Citation: K. Fife et M. Bower, RECENT INSIGHTS INTO THE PATHOGENESIS OF KAPOSIS-SARCOMA, British Journal of Cancer, 73(11), 1996, pp. 1317-1322
A LARGE-SCALE, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL OF PERORAL VALACICLOVIR FOR EPISODIC TREATMENT OF RECURRENT HERPES GENITALIS
Authors: SPRUANCE SL TYRING SK DEGREGORIO B MILLER C BEUTNER K ALSEVER J DANDRESMITH V APPEL T BEAUFORD W BERNSTEIN DI BROOKS J CAMERON W WALD A DAVIDBAJAR KM DAVIS R FARO S FIFE K FISHER GB FRIEDMAN D GOLDBERG L GORDON S GRATKINS L HANSON M HAVLICHEK D HINO P KAUFMAN RH KURTZ T LANG W LAPPIN M LEBWOHL M LEVIN ML LEVIN M MERTZ GJ REITANO MV REZA L ROTH R RUDOLPH T SAFRIN S STEPHENS S TIPTON N TRUPIN S VANAMERONGEN D WANEK E WHITING D WRIGHT B YOCKEY C ZELLNER SR DELEHANTY JT DIX L CHULAY JD
Citation: Sl. Spruance et al., A LARGE-SCALE, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL OF PERORAL VALACICLOVIR FOR EPISODIC TREATMENT OF RECURRENT HERPES GENITALIS, Archives of internal medicine, 156(15), 1996, pp. 1729-1735
HUMAN CHORIONIC-GONADOTROPIN FOR AID-RELATED KAPOSIS-SARCOMA
Authors: BOWER M FIFE K NELSON M YOULE M
Citation: M. Bower et al., HUMAN CHORIONIC-GONADOTROPIN FOR AID-RELATED KAPOSIS-SARCOMA, Lancet, 346(8975), 1995, pp. 642-642
DIAGNOSIS OF HERPES-SIMPLEX ENCEPHALITIS - APPLICATION OF POLYMERASE CHAIN-REACTION TO CEREBROSPINAL-FLUID FROM BRAIN-BIOPSIED PATIENTS ANDCORRELATION WITH DISEASE
Authors: LAKEMAN FD WHITLEY RJ ALFORD C COBBS CG MORAWETZ R SOONG S HIRSCH MS DOLAN R BETTS R REICHMAN R COREY L LEVIN M HANDLEY D CONNER J SPECTOR S OXMAN M RICHMAN D HAYDEN F GREENLEE J LINNEMANN C POWELL D DURAK D POLLARD R JONCAS J ARVIN A YEAGER A WRIGHT P EDWARDS C KLEIMAN M FIFE K LIU K HINTHORN D PAZIN G HO M BARINGER R COHEN M LEMON S CHOW A WEIL M TILLES J
Citation: Fd. Lakeman et al., DIAGNOSIS OF HERPES-SIMPLEX ENCEPHALITIS - APPLICATION OF POLYMERASE CHAIN-REACTION TO CEREBROSPINAL-FLUID FROM BRAIN-BIOPSIED PATIENTS ANDCORRELATION WITH DISEASE, The Journal of infectious diseases, 171(4), 1995, pp. 857-863
PHASE-II DOSE-RANGING TRIAL OF FOSCARNET SALVAGE THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN AIDS PATIENTS INTOLERANT OF OR RESISTANT TO GANCICLOVIR (ACTG PROTOCOL 093)
Authors: JACOBSON MA WULFSOHN M FEINBERG JE DAVIS R POWER M OWENS S CAUSEY D HEATHCHIOZZI ME MURPHY RL CHEUNG TW DIETERICH DT SPECTOR SA MCKINLEY GF PARENTI DM CRUMPACKER C NISHIMOTO B LEEDOM JM KRAMER F COHEN C LOFTUS J KESSLER HA POTTAGE JC BENSON CA PHAIR JP GERITS P CHUSID E SACKS HS FRIEDBERG D CURRANKRIKORIAN K VALENTINE FT MENG TC FREEMAN WR MEIXNER L RICHMAN D ODONNELL JJ KIMBRELL C BOGGIO K LARSON J WHITMORE PV SIMON GL LELACHEUR S FIFE K ZWICKL B RELUE J STEIGBIGEL RT FUHRER J DONLON W BURK RA PORTMORE AC WEISSBACH NE HOOTON TM HOLZWORTH P DAVISON S COLLIER AC POWDERLY WG KLEBERT M ROYAL M SEYFRIED W SQUIRES KC WEISS W BARBACCI M BECKER RL JABS D BARTLETT JG PARA MF JONES M NEIDIG JL FASS RJ VANDERHORST C KYLSTRA J RAASCH R BLOODGOOD K WOLITZ R KIRK S ROLFE L PATRONEREESE J BARTLETT JA WASKIN HA WILLIAMS DK SHIP KW KAHL P ASSAYKEEN T KAROL C MARTINMUNLEY S SUMNER P
Citation: Ma. Jacobson et al., PHASE-II DOSE-RANGING TRIAL OF FOSCARNET SALVAGE THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN AIDS PATIENTS INTOLERANT OF OR RESISTANT TO GANCICLOVIR (ACTG PROTOCOL 093), AIDS, 8(4), 1994, pp. 451-459
RISK-FACTORS FOR REQUIRING CATARACT-SURGERY FOLLOWING TOTAL-BODY IRRADIATION
Authors: FIFE K MILAN S WESTBROOK K POWLES R TAIT D
Citation: K. Fife et al., RISK-FACTORS FOR REQUIRING CATARACT-SURGERY FOLLOWING TOTAL-BODY IRRADIATION, Radiotherapy and oncology, 33(2), 1994, pp. 93-98
Risultati: 1-16 |